Salarius Pharmaceuticals
Pre-clinicalSalarius Pharmaceuticals develops small molecule therapies targeting epigenetic mechanisms for cancer treatment.
Founded
2012
Focus
Biologics
About
Salarius Pharmaceuticals develops small molecule therapies targeting epigenetic mechanisms for cancer treatment.
Funding History
2Total raised: $25M
PIPE$10MUndisclosedNov 15, 2021
Series A$15MUndisclosedMay 15, 2018
Company Info
TypePrivate
Founded2012
LocationHouston, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile